Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is headquartered in Radnor, Pennsylvania. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky” Mineralys is a fully remote company. Our Medical Affairs team is growing and we are currently seeking a Director of Publications to join our diverse and dynamic team. In this role, you will be responsible for Medical Affairs Publications and will play a strategic role providing expertise for development, management and dissemination of our publication plans supporting hypertension, chronic kidney disease and sleep apnea. This will include the execution of clinical and disease state publications. Responsibilities include leading cross-functional publication teams to develop, manage, and implement publication plans for our therapeutic areas.